Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Indoxyl sulfate (IS)-CTSK axis mediates cardiac fibroblast activation in CKD-Related HFpEF

Chronic kidney disease (CKD) is frequently complicated by heart failure with preserved ejection fraction (HFpEF), a phenotype characterized by diastolic dysfunction, myocardial fibrosis, and limited therapeutic options [1]. Uremic toxins, particularly indoxyl sulfate (IS), are increasingly recognized as critical...

Y. Zou, C. Ma, J. Wang et al. · 0 citations
Open access Sep 2026

The PKMYT1-ALDOA axis drives chemoresistance in cholangiocarcinoma by enhancing glycolysis and MRE11 lactylation.

Cholangiocarcinoma (CCA) is a highly aggressive biliary malignancy with limited responses to existing treatments. Gemcitabine plus cisplatin (GC) remains the standard first-line chemotherapy for advanced disease, but its clinical efficacy is suboptimal, and drug resistance frequently emerges in patients. Through high-t...

Wei Wu, J. Wang, Wu Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.